Replies to post #257537 on Biotech Values

[Whalatane]

I thought he was a positive for RZLT so hopefully the changes he initiated will stay in place.
Probably the only way RZLT's pediatric indication ever gets approved is if the FDA places a lot of weight on follow up extension data , real world evidence and doesnt require a new trial.
Doubt it has much impact on UNCY . UNCY either pass's the manufacturing inspection by June 29th ..or it doesn't. Its not a clinical data decision ...that was fine
JMO
Kiwi